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ABSTRACT 
Drabbová, A.: Title of Diploma Thesis: Centaurea cyanus L. (Asteraceae) alkaloids and their 
biological activity related to Alzheimer's disease. Charles University, Faculty of Pharmacy 
in Hradec Králové, Department of Pharmaceutical Botany, Hradec Králové 2020. 
 
Ethyl acetate and chloroform alkaloids extracts were prepared from Centaurea cyanus L. 
seeds. A novel alkaloid AD-1 (Adrabbin) was isolated from the ethyl acetate extract by 
common chromatografic methods (column chromatography, preparative TLC). Its structure 
was elucidated by mass spektrometry, NMR analysis and determination of optical rotation. 
The alkaloid AD-1 (Adrabbin) possesses a unique structure which consists of a cyclic indole 
moiety. Also LC-MS analysis of fractions obtained by flash chromatography was performed. 
In those fractions were detected molecular ions related to compounds previously isolated from 
other Centaurea species.  
Alkaloid AD-1 (Adrabbin) was tested on ability to inhibit human cholinesterases, prolyl 
oligopeptidase and gylcogen synthase kinase 3β. The compound was considered against 
human cholinesterases inactive (IC50 values > 100 µM). Interestibgly, the alkaloid inhibited 
prolyl oligopeptidase the same intensity as a standard berberine (AD-1: IC50 143,0 ± 6,0 µM; 
berberin: IC50 142,0 ± 21,0 µM). The novel compound has not been tested yet on inhibition of 
glycogen synthase-kinase 3β due to the current COVID-19 pandemic.  
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